Well | RefSeq | Symbol | Description | T-test | Fold Difference |
---|---|---|---|---|---|
 |  |  |  | P value | (LPS + rSjCa8)/LPS |
A02 | NM_028717 | Als2 | Amyotrophic lateral sclerosis 2 (juvenile) homolog (human) | 3.38E-04 | −4.14 |
A04 | NM_007527 | Bax | Bcl2-associated X protein | 6.11E-08 | 10.79 |
A05 | NM_009743 | Bcl2l1 | Bcl2-like 1 | 4.58E-06 | −3.43 |
A08 | NM_009795 | Capns1 | Calpain, small subunit 1 | 1.58E-03 | −3.57 |
A09 | NM_009804 | Cat | Catalase | 4.22E-07 | 1012.32 |
B01 | NM_016892 | Ccs | Copper chaperone for superoxide dismutase | 2.32E-08 | −13.69 |
B03 | NM_007669 | Cdkn1a | Cyclin-dependent kinase inhibitor 1A (P21) | 1.47E-04 | −7.75 |
B05 | NM_007806 | Cyba | Cytochrome b-245, alpha polypeptide | 2.05E-04 | −7.35 |
B08 | NM_007864 | Dlg4 | Discs, large homolog 4 (Drosophila) | 8.65E-05 | −9.50 |
C01 | NM_007987 | Fas | Fas (TNF receptor superfamily member 6) | 1.30E-04 | −279.80 |
C02 | NM_010234 | Fos | FBJ osteosarcoma oncogene | 3.73E-05 | −14.66 |
C04 | NM_007836 | Gadd45a | Growth arrest and DNA-damage-inducible 45 alpha | 2.80E-08 | −367.26 |
C05 | NM_008160 | Gpx1 | Glutathione peroxidase 1 | 1.12E-04 | −5.45 |
C07 | NM_008161 | Gpx3 | Glutathione peroxidase 3 | 2.58E-05 | −23.15 |
D01 | NM_010439 | Hmgb1 | High mobility group box 1 | 2.78E-07 | −41.98 |
D02 | NM_008281 | Hpn | Hepsin | 4.79E-04 | −3.87 |
D03 | NM_010497 | Idh1 | Isocitrate dehydrogenase 1 (NADP+), soluble | 3.20E-06 | −8.61 |
D04 | NM_008326 | Irgm1 | Immunity-related GTPase family M member 1 | 2.26E-04 | −8.25 |
D05 | NM_010786 | Mdm2 | Transformed mouse 3 T3 cell double minute 2 | 1.09E-05 | −14.94 |
D07 | NM_010849 | Myc | Myelocytomatosis oncogene | 1.18E-09 | −1868.05 |
D08 | NM_010877 | Ncf2 | Neutrophil cytosolic factor 2 | 1.32E-04 | −3.86 |
D09 | NM_008682 | Nedd1 | Neural precursor cell expressed, developmentally down-regulated gene 1 | 2.38E-06 | −18.38 |
D12 | NM_010927 | Nos2 | Nitric oxide synthase 2, inducible | 1.46E-06 | −15.64 |
E02 | NM_172203 | Nox1 | NADPH oxidase 1 | 1.46E-06 | −3.30 |
E07 | NM_011063 | Pea15a | Phosphoprotein enriched in astrocytes 15A | 3.44E-05 | −11.22 |
E08 | NM_133819 | Ppp1r15b | Protein phosphatase 1, regulatory (inhibitor) subunit 15b | 5.35E-08 | −7.67 |
E09 | NM_008913 | Ppp3ca | Protein phosphatase 3, catalytic subunit, alpha isoform | 3.61E-07 | −24.03 |
E10 | NM_011034 | Prdx1 | Peroxiredoxin 1 | 3.28E-04 | −4.18 |
E11 | NM_011563 | Prdx2 | Peroxiredoxin 2 | 1.30E-06 | −12.04 |
E12 | NM_007453 | Prdx6 | Peroxiredoxin 6 | 3.91E-04 | −3.19 |
F02 | NM_011170 | Prnp | Prion protein | 5.97E-05 | −12.71 |
F06 | NM_009029 | Rb1 | Retinoblastoma 1 | 2.40E-05 | −16.42 |
F07 | NM_058214 | Recql4 | RecQ protein-like 4 | 4.72E-07 | −11.70 |
F09 | NM_009101 | Rras | Harvey rat sarcoma oncogene, subgroup R | 4.22E-07 | −16.76 |
F10 | NM_009127 | Scd1 | Stearoyl-Coenzyme A desaturase 1 | 1.01E-07 | −35.25 |
F11 | NM_009128 | Scd2 | Stearoyl-Coenzyme A desaturase 2 | 7.52E-05 | −6.71 |
F12 | NM_024450 | Scd3 | Stearoyl-coenzyme A desaturase 3 | 3.54E-04 | −7.59 |
G02 | NM_011434 | Sod1 | Superoxide dismutase 1, soluble | 1.78E-03 | −4.30 |
G03 | NM_013671 | Sod2 | Superoxide dismutase 2, mitochondrial | 5.07E-08 | −232.28 |
G06 | NM_011640 | Trp53 | Transformation related protein 53 | 1.09E-04 | −9.62 |
G07 | NM_023719 | Txnip | Thioredoxin interacting protein | 7.36E-09 | −325.89 |
G08 | NM_013711 | Txnrd2 | Thioredoxin reductase 2 | 6.01E-08 | −37.67 |
G09 | NM_019639 | Ubc | Ubiquitin C | 1.28E-04 | −4.20 |
G11 | NM_026119 | Med4 | Mediator of RNA polymerase II transcription, subunit 4 homolog (yeast) | 2.78E-06 | −3.39 |
H01 | NM_010368 | Gusb | Glucuronidase, beta | 4.77E-02 | −5.90 |
H02 | NM_013556 | Hprt1 | Hypoxanthine guanine phosphoribosyl transferase 1 | 1.60E-05 | −23.66 |
H04 | NM_008084 | Gapdh | Glyceraldehyde-3-phosphate dehydrogenase | 1.60E-04 | −6.13 |
H05 | NM_007393 | Actb | Actin, beta | 3.51E-03 | −8.43 |